VRTX
Vertex Pharmaceuticals Inc
502.30$
-0.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -303.0% | -21.5% | -70.0% | -51.6% | -21.3% | -4.8% | -49.4% | -242.4% | -138.4% | -106.9% | -10.4% | -126.9% | -129.0% | -419.0% | -443.2% | 10.2% | 17.5% | -4.3% | -88.4% | -35.4% | 13.9% | 34.0% | 41.7% | 37.7% | 52.4% | 34.9% | 46.2% | 35.8% | -4.5% | 30.1% | |
| 24.1% | 8.2% | 10.1% | 10.2% | 11.6% | 10.7% | 15.8% | 33.9% | 28.9% | 17.0% | 12.0% | 13.8% | 18.3% | 29.5% | 21.2% | 2.5% | 2.5% | 4.0% | 10.9% | 6.0% | 3.6% | 2.5% | 2.4% | 2.6% | 1.8% | 1.7% | 1.7% | 1.8% | 1.9% | 1.7% | |
| – | – | – | – | – | – | 0.9% | 4.6% | 4.1% | 4.7% | 18.1% | 29.9% | 35.9% | 85.0% | 68.1% | 9.0% | 7.5% | 10.5% | 30.6% | 22.4% | 14.0% | 11.7% | 10.7% | 8.7% | 6.9% | 5.8% | 5.5% | 5.9% | 6.3% | 5.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 96.9% | 17.6% | 16.8% | 72.4% | 30.5% | 23.5% | 14.3% | 32.0% | 12.6% | 9.2% | 8.4% | 6.0% | 5.0% | – | – | – | |
| -24.8% | 15.8% | -4.3% | 2.4% | 12.5% | 24.5% | 0.5% | 99.7% | -12.4% | -32.4% | 56.9% | 23.8% | 79.1% | 60.2% | -44.5% | -13.7% | -0.9% | -0.4% | -1.9% | -8.3% | -0.1% | 0.6% | 7.8% | -1.6% | -0.9% | -1.4% | 3.8% | -2.7% | -4.7% | -9.9% | |
| 30.1% | 13.7% | 17.8% | 26.3% | 15.2% | 32.2% | 25.6% | 25.1% | 12.2% | 10.5% | 15.0% | 16.3% | 18.3% | 23.0% | 26.5% | 6.7% | 4.7% | 4.2% | 8.8% | 4.4% | 3.3% | 10.4% | 3.1% | 1.8% | 4.2% | 3.1% | 2.3% | 2.6% | 2.7% | 3.6% | |
| -303.8% | -271.2% | -45.9% | 59.1% | -302.5% | -86.6% | -9.9% | 173.0% | 104.6% | -1.1% | -96.4% | 203.6% | -205.5% | -498.5% | 5.1% | 15.1% | -27.9% | -4.5% | 12.7% | 26.0% | 6.1% | -17.6% | -6.6% | -29.7% | 1.6% | -4.5% | -3.6% | -31.8% | -34.2% | -7.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 284.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 0.2% | 4.3% | 1.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 284.7% | 23.3% | 8.9% | 12.6% | 21.9% | 47.3% | 18.0% | 4.0% | 13.9% | -11.5% | -4.6% | -11.9% | -20.6% | -1.9% | -4.3% | -10.7% | -16.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 273.2% | -17.7% | -0.2% | -1.3% | 48.4% | 0.4% | -0.6% | -11.4% | -0.2% | -0.8% | -0.5% | -0.3% | -1.0% | -0.5% | -0.3% | 0.0% | |
| 654.9% | 376.3% | 9.5% | 4.5% | 696.3% | -2.4% | 8.6% | 54.2% | -8.4% | 122.7% | 169.1% | -5.1% | 353.7% | 978.9% | 296.5% | -8.8% | 11.3% | 14.9% | 85.7% | 18.3% | 7.8% | 2.7% | -2.3% | 3.0% | -8.1% | -19.5% | -0.8% | -5.7% | -13.6% | -18.7% | |
| 654.9% | 376.3% | 9.5% | 11.9% | 371.9% | -94.0% | -50.4% | -14.4% | -42.0% | 14.3% | 62.5% | 71.6% | 19.1% | 56.4% | -141.9% | 16.5% | 0.9% | 6.6% | 9.6% | 8.7% | 27.6% | 19.3% | 32.5% | 11.1% | 46.2% | 10.7% | 41.6% | -1.4% | -52.6% | 4.3% | |
| -333.1% | -35.2% | -87.8% | -77.9% | -36.6% | -37.0% | -75.0% | -267.5% | -150.6% | -117.5% | -25.4% | -143.2% | -147.4% | -442.0% | -469.8% | 3.5% | 12.9% | -8.5% | -97.2% | -39.8% | 10.5% | 23.5% | 38.5% | 35.9% | 48.2% | 31.8% | 44.0% | 33.2% | -7.2% | 26.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.